Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-21

FDA Approved: PIOGLITAZONE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for pioglitazone hydrochloride (pioglitazone) from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pioglitazone hydrochloride (Pioglitazone hydrochloride)

Snippet

SUPPL AP for PIOGLITAZONE HYDROCHLORIDE (PIOGLITAZONE HYDROCHLORIDE)